Blake Scott

No open positions remaining

Finance

Consumer Services

Profile

Dr. Blake Scott is a Vice President & Research Analyst at Aquilo Capital Management LLC.
Dr. Scott joined McKinsey & Co.’s New York office as a management consultant.
He served a range of pharmaceutical clients, including projects on regulatory, commercial, and R&D considerations.
He supported diligence on immuno-oncology portfolios, assets, biotechnology partnerships, and overall research strategies.
He helped develop strategies to improve clinical trial design and oversight for oncology trials, and supported the management in large mergers and acquisitions in the pharmaceutical space.
Dr. Scott completed his PhD in Cellular and Molecular Medicine at the Johns Hopkins School of Medicine,

Former positions of Blake Scott

Companies	Position	End
Aquilo Capital Management LLC Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time.	Analyst-Equity	01/11/2022

See the detail of Blake Scott's experience

Training of Blake Scott

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Blake Scott's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Aquilo Capital Management LLC Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time.	Finance
The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services

Private companies

Finance